Gene-ius at stake: who really cracked CRISPR in plants and animals?
3 June 2025
Many of our readers will have first heard of CRISPR-Cas9 a number of years ago.
Read on
Patents
One year on: the Treaty, WIPO, Traditional Knowledge, and patents
15 May 2025
Imagine an organisation obtaining patent protection over a formulation derived from Kakadu plum, while the First Nations community whose Knowledge guided the discovery receives neither recognition nor benefit.
Read on
Stop! In the name of interlocutory injunctions: lessons from 2024
17 March 2025
Interlocutory injunctions can be a critical tool to help protect intellectual property rights by restraining alleged infringement while a substantive infringement proceeding is run.
Read on
Substance over form(ulations)? An update on patent term extensions
18 February 2025
Two recent Federal Court decisions illustrate that term extensions are available for a broad range of patents, including formulation patents.
Read on
The patentability of software in the US
12 November 2024
We are lucky to share with you insights from our New York patent experts Charles Wizenfeld, Michael S.
Read on
Proposed modifications to the regulation of gene technology in Australia
4 November 2024
The Department of Health and Aged Care is proposing the first major amendments to the Gene Technology Act 2000 (Cth) (the Act) since its commencement.
Read on
The mRNA patent wars: lessons for businesses & organisations who rely on patent rights
28 October 2024
Two weeks ago, GlaxoSmithKline (GSK) filed proceedings against the makers of the COVID-19 SPIKEVAX® vaccine, Moderna, Inc in the US Federal District Court in Delaware alleging that Moderna has infringed its patents relating to messenger RNA (mRNA) technology.
Read on
Get used to spl(it)! Patentees can elect damages or account of profits for each act of infringement
8 October 2024
Earlier this year, the Federal Court in Australian Mud Company Pty Ltd v Globaltech Corporation Pty Ltd (No 5) endorsed a split election for damages and an account of profits in a quantum decision for patent infringement.[1] This is the first time this issue has been decided (previous orders for split election were made by consent) and would allow a patentee to elect damages or an account of profits for each act of infringement to maximise compensation.
Read on
China and United States see eye to IP
7 February 2020
On 15 January 2020, China and the United States (US) signed “Phase One” of the Economic and Trade Agreement (‘ETA’), signalling an armistice of the trade war that has significantly impacted two of the world’s largest economies (not to mention the rest of us).
Read on
Patent Wars: A New Hope (or, the Inventor Strikes Back!)
20 November 2019
On 23 October 2019, the Supreme Court of the United Kingdom handed down its highly anticipated decision in Shanks v Unilever Plc and others [2019] UKSC 45.
Read on
Load More Posts